Cancer cell-derived extracellular vesicles (EVs) can modify the prostate microenvironment to promote cancer proliferation [157] and can promote the activation of the NLRP3 inflammasome and caspase-1 and IL-1β release, contributing to the maintenance of proinflammatory tumor conditions [93]. This evidence concerns the gene CASP1 and neoplasm.